Related Experiment Video
Updated: Jul 16, 2026

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Published on: June 8, 2014
Impaired osteoblastic differentiation, reduced bone formation, and severe osteoporosis in noggin-overexpressing mice
Xue-Bin Wu1, Yanan Li, Adina Schneider
1Division of Endocrinology, Diabetes, and Bone Diseases, Mount Sinai School of Medicine, One Gustave L. Levy Place, Box 1055, New York, New York 10029, USA.
Abstract:
We describe the effects of the overexpression of noggin, a bone morphogenetic protein (BMP) inhibitor, on osteoblast differentiation and bone formation. Cells of the osteoblast and chondrocyte lineages, as well as bone marrow macrophages, showed intense beta-gal histo- or cytostaining in adult noggin+/- mice that had a LacZ transgene inserted at the site of noggin deletion. Despite identical BMP levels, however, osteoblasts of 20-month-old C57BL/6J and 4-month-old senescence-accelerated mice (SAM-P6 mice) had noggin expression levels that were approximately fourfold higher than those of 4-month-old C57BL/6J and SAM-R1 (control) mice, respectively. U-33 preosteoblastic cells overexpressing the noggin gene showed defective maturation and, in parallel, a decreased expression of Runx-2, bone sialoprotein, osteocalcin, and RANK-L. Noggin did not inhibit the ligandless signaling and pro-differentiation action of the constitutively activated BMP receptor type 1A, ca-ALK-3. Transgenic mice overexpressing noggin in mature osteocalcin-positive osteoblasts showed dramatic decreases in bone mineral density and bone formation rates with histological evidence of decreased trabecular bone and CFU-osteoblast colonies at 4 and 8 months. Together, the results provide compelling evidence that noggin, expressed in mature osteoblasts, inhibits osteoblast differentiation and bone formation. Thus, the overproduction of noggin during biological aging may result in impaired osteoblast formation and function and hence, net bone loss.
Insights
Overexpression of noggin, a bone morphogenetic protein inhibitor, impairs osteoblast differentiation and bone formation. Increased noggin levels during aging may contribute to bone loss.
Area of Science:
- Bone Biology
- Skeletal Development
- Aging
Background:
- Noggin is a key inhibitor of bone morphogenetic proteins (BMPs).
- Dysregulation of BMP signaling is implicated in bone disorders.
- The role of noggin in mature osteoblasts and aging bone is not fully understood.
Purpose of the Study:
- To investigate the impact of noggin overexpression on osteoblast differentiation and bone formation.
- To explore the potential role of noggin in age-related bone loss.
Main Methods:
- Utilized transgenic mice with noggin overexpression in osteoblasts.
- Employed cell culture models (U-33 preosteoblastic cells).
- Assessed gene expression (Runx-2, osteocalcin, RANK-L) and bone parameters (bone mineral density, bone formation rates).
Main Results:
- Noggin overexpression in osteoblasts led to defective maturation and reduced expression of key bone markers.
- Transgenic mice showed decreased bone mineral density and impaired bone formation.
- Elevated noggin levels were observed in aged mice, correlating with impaired osteoblast function.
Conclusions:
- Noggin, when expressed in mature osteoblasts, inhibits osteoblast differentiation and bone formation.
- Increased noggin production during aging may contribute to age-related bone loss.
- Targeting noggin may offer therapeutic potential for bone diseases.
Related Concept Videos
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Osteoclasts in Bone Remodeling
Bone Formation by Intramembranous Ossification
The process begins when mesenchymal cells in the embryonic skeleton gather together and differentiate into osteogenic cells, which then develop into...
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone Remodeling and Repair

